Because the GK921-binding site overlaps with that of p53, the compound also prevents TGase 2 from binding to p53 in RCC cells, thereby stabilizing the tumor suppressor protein [24] (Figure 1). This evidence concerns the gene TP53 and renal cell adenocarcinoma.